FDA Authorizes Fruit-Flavored Vapes, Finds No Quit‑Rate Advantage Over Tobacco Flavors

Fruit‑flavored e‑cigarettes recently authorized by the FDA were not shown to be more effective at helping smokers quit than tobacco‑flavored products, according to a new agency memorandum.

Last month, the FDA granted its first approval for fruit‑flavored vapes, positioning them as a potentially reduced‑harm alternative to traditional cigarettes. The decision was made despite the agency’s longstanding view that such flavors attract youth and must demonstrate additional health benefits for adult users.

Health organizations and several members of Congress swiftly criticized the move and demanded an explanation.

The six‑page FDA memo released this week offers further insight into the agency’s reasoning. Regulators appear to set aside earlier statements about the risks of sweet flavors while acknowledging gaps in the data submitted by Glas Inc.

To satisfy federal standards, manufacturers must prove that their products benefit public health—specifically, that they help adult smokers switch away from cigarettes without encouraging underage use.

In a three‑month study, smokers who tried Glas vapes were more likely to fully switch from cigarettes, the memo notes.

However, the results did not demonstrate statistically significant differences between adults using the company’s mango and blueberry flavors and those using a tobacco‑flavored e‑cigarette.

This shortfall means the new flavors did not meet the evidentiary threshold achieved by other flavored products previously authorized by the FDA, such as menthol vapes from Juul and NJOY, which showed a clear benefit for adult quitting rates.

FDA officials also indicated that Glas’s flavored vapes “did not have to demonstrate added adult benefit” because they are unlikely to be used by youth; the devices require an age‑verifying mobile app to unlock each unit.

The authorization contrasts with recent FDA guidance that fruit and dessert flavors must meet a “high evidentiary burden” for adult use due to their appeal to children. Tobacco‑flavored products are less popular with teens and generally face fewer regulatory obstacles.

The memo’s brevity is notable. Prior FDA memoranda on vaping products typically span dozens of pages; for example, last year’s approval of Juul’s menthol e‑cigarettes exceeded 90 pages and included extensive data from studies involving 50,000 participants.

The Glas memo lacks key details, such as the number of smokers studied, and was posted on the agency’s website more than a month after the products were cleared.

Congressional members have questioned the decision. In November, ten Democratic senators sent a letter to the FDA calling the approval “shortsighted and reckless” and requesting additional information.

Glas’s application, which also covered menthol and tobacco‑flavored vapes, followed a protracted path to approval. The Los Angeles‑based company filed a marketing request in 2021, which was initially rejected.

In February, FDA scientists reversed course and approved several flavors, but a senior official reporting to then‑Commissioner Marty Makary blocked the decision, according to internal memos.

The mango and blueberry flavors were ultimately authorized during Makary’s final full week as commissioner. He resigned after months of criticism from industry groups, including tobacco companies that have lobbied the Trump administration for looser vaping regulations.

A company spokesperson was not immediately available for comment on Thursday morning.

Source link